| 张 庆,李 露,杨 婧,等.2019年甘肃省肿瘤登记地区脑及中枢神经系统恶性肿瘤流行特征及2010—2019年变化趋势分析[J].中国肿瘤,2024,33(2):111-117. |
| 2019年甘肃省肿瘤登记地区脑及中枢神经系统恶性肿瘤流行特征及2010—2019年变化趋势分析 |
| Epidemiological Characteristics of Malignant Tumors of Brain and Central Nervous System in Cancer Registration Areas of Gansu Province in 2019 and Trend from 2010 to 2019 |
| 投稿时间：2023-11-10 |
| DOI：10.11735/j.issn.1004-0242.2024.02.A005 |
|
 |
| 中文关键词: 脑及中枢神经系统恶性肿瘤 发病率 死亡率 变化趋势 甘肃 |
| 英文关键词:malignant tumors of brain and central nervous system incidence mortality trend of change Gansu |
| 基金项目: |
|
| 摘要点击次数: 128 |
| 全文下载次数: 79 |
| 中文摘要: |
| 摘 要：［目的］ 分析2019年甘肃省肿瘤登记地区脑及中枢神经系统恶性肿瘤发病与死亡现状及2010—2019年变化趋势。［方法］ 根据甘肃省肿瘤登记地区上报的2010—2019年脑及中枢神经系统恶性肿瘤数据，计算发病(死亡)例数、粗发病率（死亡率）、年龄别发病率（死亡率）、累积率（0～74岁）、截缩率（35～64岁）、标化发病（死亡）率。中国人口标化率（简称为中标率）根据2000年全国普查标准人口的年龄构成计算，世界人口标化率（简称为世标率）根据Segi世界标准人口年龄构成计算。运用Joinpoint软件计算年度变化百分比（APC）与平均年度变化百分比（AAPC）。［结果］ 2019年甘肃省肿瘤登记地区脑及中枢神经系统恶性肿瘤新发病例数为778例，其中男性346例，女性432例，发病率为8.39/10万，中标率为6.35/10万，世标率为6.20/10万，0~74岁累积率为0.44%；脑及中枢神经系统恶性肿瘤死亡病例数为332例，其中男性188例，女性144例，死亡率为3.58/10万，中标率为2.60/10万，世标率为2.57/10万，0～74岁累积率为0.15%。农村中标发病率为城市的1.49倍，中标死亡率为城市的1.61倍。脑及中枢神经系统恶性肿瘤年龄别发病率和死亡率都是在75～79岁年龄组达到最高水平，男性发病率最高出现在80～84岁年龄组，而死亡率则是在75～79岁年龄组，女性发病率和死亡率最高分别出现在75～79岁和85岁及以上年龄组。2010—2019年甘肃省肿瘤登记地区脑及中枢神经系统恶性肿瘤中标发病率AAPC为3.21%（95%CI：-0.32%～10.58%），中标死亡率AAPC为-0.05%(95%CI：-1.85%～3.08%)。［结论］ 甘肃省脑及中枢神经系统恶性肿瘤发病率高于全国平均水平，属于甘肃省重要公共卫生问题，严重影响人们的生活质量，因此应继续加强对脑及中枢神经系统恶性肿瘤的防控，积极推进高危人群筛查工作。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence and mortality rates of malignant tumors of brain and central nervous system in cancer registration areas of Gansu Province in 2019 and the trend from 2010 to 2019.［Methods］ Based on the data of malignant tumors of brain and central nervous system reported by the cancer registration areas of Gansu Province from 2010 to 2019， the number of cases (deaths)， crude incidence (mortality) rate， age-specific incidence (mortality) rate， cumulative rate (0~74 years old)， truncated rate (35~64 years old) and standardized incidence (mortality) rate were calculated. The standardized rate of the Chinese population (ASRC) was calculated based on the standard population of the 2000 National Census， and the world population standardized rate (ASRW) was calculated based on the Segi’s world standard population. Annual percentage change(APC) and average annual percentage change(AAPC) was calculated using Joinpoint software.［Results］ In 2019， the number of new cases of malignant tumors of brain and central nervous system in Gansu cancer registration areas was 778， of which there were 346 in male and 432 in female， with an incidence rate of 8.39/105， ASRC of 6.35/105， ASRW of 6.20/105， and cumulative rate (0~74 years old) of 0.44%； and the number of deaths from malignant tumors of brain and central nervous system was 332， of which there were 188 in male and 144 in female， with a mortality rate of 3.58/105， ASRC of 2.60/105， ASRW of 2.57/105， and cumulative rate(0~74 years old) of 0.15%. The ASIRC in rural areas was 1.49 times that of urban areas， and the ASMRC was 1.61 times that of urban areas. Additionally， the age-specific incidence and mortality rates of malignant tumors of brain and central nervous system reached the highest level in the age group of 75~79 years old. The highest incidence for male occurred in the age group of 80~84 years old， while the highest mortality occurred in the age group of 75~79 years old. The highest incidence and mortality for female occurred in the age groups of 75~79 years old and over 85 years old， respectively. From 2010 to 2019， the AAPC of malignant tumors of brain and central nervous system was 3.21% (95%CI： -0.32%~10.58%)， and the AAPC of mortality was -0.05%(95%CI：-1.85%~3.08%).［Conclusion］ The incidence of brain and central nervous system malignant tumors in Gansu Province is higher than the national average， which is an important public health problem in Gansu Province and will seriously affect people’s quality of life. Therefore， we should continue to strengthen the prevention and control of brain and central nervous system malignant tumors and actively promote the screening of high-risk groups. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |